Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05371834 · ClinicalTrials.gov registry record · NA

Microwave Treatment of Common and Plantar Warts

A NA study of Warts, sponsored by Blackwell Device Consulting.

Active
Registry status
NA
Development phase
119
Enrollment target
6
Study locations

NCT05371834 is a NA study of Warts that is active but no longer recruiting, run by Blackwell Device Consulting. The registered enrollment target is 119 participants, below the 205-participant average among 7 other Warts trials with a reported enrollment target (42% lower). The trial reports 6 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05371834, a NA study of Warts, is active but no longer recruiting, sponsored by Blackwell Device Consulting.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
119 participants
Enrollment target
6
Study locations

Study Summary

This is a multi-center, open, randomized, parallel-group, controlled, blind-assessed trial of approximately 124 subjects that require treatment for up to 5 common or plantar warts. Subjects will be randomized to one of two treatment groups: Microwave Treatment (Swift® system) or Cryotherapy.

Conditions Studied

Interventions

  • DEVICE Cryotherapy
  • DEVICE Microwave Treatment (Swift System)

Study Locations (6)

Florida

  • Miami Dermatology and Laser Institute - Miami
  • TrueBlue Clinical Research - Palm Harbor
  • TrueBlue Clinical Research - Tampa

Illinois

  • Weil Foot & Ankle Institute - Chicago
  • Oak Dermatology - Naperville

Tennessee

  • Tennessee Clinical Research Center - Nashville

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2022-07-06
Est. Completion 2025-03
Phase NA

Sponsor

Blackwell Device Consulting

2 total trials

What the Registry Record Tells You About NCT05371834

The ClinicalTrials.gov registry entry for NCT05371834 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 7 other Warts trials with a reported enrollment target (42% lower). The listed sponsor is Blackwell Device Consulting, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Warts appearing as the primary indexed condition, and to 2 interventions - of which Cryotherapy is the first listed.

NCT05371834 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Florida, Illinois, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05371834 about?

NCT05371834 is a clinical study titled "Microwave Treatment of Common and Plantar Warts". This is a multi-center, open, randomized, parallel-group, controlled, blind-assessed trial of approximately 124 subjects that require treatment for up to 5 common or plantar warts. Subjects will be randomized to one of two treatment groups: Microwave Treatment (Swift® system) or Cryotherapy.

What is the current status of trial NCT05371834?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 119 participants. The study started on 2022-07-06. Estimated completion is 2025-03.

What conditions does trial NCT05371834 study?

This clinical trial studies the following conditions: Warts.

What interventions are being tested in trial NCT05371834?

The interventions under investigation include: Cryotherapy (DEVICE), Microwave Treatment (Swift System) (DEVICE).

Who is sponsoring clinical trial NCT05371834?

This trial is sponsored by Blackwell Device Consulting, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05371834 being conducted?

This trial has 6 study locations across Florida, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Warts

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.